90 related articles for article (PubMed ID: 27279798)
21. HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
Ratnam S; Jang D; Alaghehbandan R; Gilbert L; Xu Y; Wang W; Andrews P; Green A; Speicher DJ; Chernesky M
Cancer Biomark; 2023; 38(4):433-442. PubMed ID: 37980645
[TBL] [Abstract][Full Text] [Related]
22. A New Test Type.
Dennett WS
Trans Am Ophthalmol Soc; 1886; 4():245-8. PubMed ID: 25259000
[No Abstract] [Full Text] [Related]
23. Test Type.
Dennett WS
Trans Am Ophthalmol Soc; 1885; 4():133-9. PubMed ID: 25258983
[No Abstract] [Full Text] [Related]
24. The Association of High Risk Human Papillomaviruses in Patients With Cervical Cancer: An Evidence Based Study on Patients With Squamous Cell Dysplasia or Carcinoma for Evaluation of 23 Human Papilloma Virus Genotypes.
Piroozmand A; Mostafavi Zadeh SM; Madani A; Soleimani R; Nedaeinia R; Niakan M; Avan A; Manian M; Moradi M; Eftekhar Z
Jundishapur J Microbiol; 2016 Apr; 9(4):e32728. PubMed ID: 27279992
[TBL] [Abstract][Full Text] [Related]
25. Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations.
Sørbye SW; Falang BM; Botha MH; Snyman LC; van der Merwe H; Visser C; Richter K; Dreyer G
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001713
[TBL] [Abstract][Full Text] [Related]
26. Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015.
Rad A; Sørbye SW; Tiwari S; Løchen ML; Skjeldestad FE
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370716
[TBL] [Abstract][Full Text] [Related]
27. 13-Type HPV DNA Test versus 5-Type HPV mRNA Test in Triage of Women Aged 25-33 Years with Minor Cytological Abnormalities-6 Years of Follow-Up.
Rad A; Sørbye SW; Brenn T; Tiwari S; Løchen ML; Skjeldestad FE
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901129
[TBL] [Abstract][Full Text] [Related]
28. Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology.
Al-Shibli K; Mohammed HAL; Maurseth R; Fostervold M; Werner S; Sørbye SW
PLoS One; 2022; 17(11):e0275858. PubMed ID: 36413537
[TBL] [Abstract][Full Text] [Related]
29. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis.
Macedo ACL; Gonçalves JCN; Bavaresco DV; Grande AJ; Chiaramonte Silva N; Rosa MI
J Oncol; 2019; 2019():6935030. PubMed ID: 31281360
[TBL] [Abstract][Full Text] [Related]
31. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
32. The potential of RNA as a target for national screening of pre-cancer.
Karlsen F; Muturi M; Muyabwa C; Roseng LE; Bigabwa S; Chihongola B; Muchiri L
J Public Health Afr; 2018 Dec; 9(3):866. PubMed ID: 30854179
[TBL] [Abstract][Full Text] [Related]
33. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou AC; Stylianou DC; Constantinidou A; Kostrikis LG
Viruses; 2018 Dec; 10(12):. PubMed ID: 30572620
[TBL] [Abstract][Full Text] [Related]
34. Analytic and Diagnostic Performances of Human Papillomavirus E6/E7 mRNA Test on up-to 11-Year-Old Liquid-Based Cervical Samples. A Biobank-Based Longitudinal Study.
Zappacosta R; Sablone F; Pansa L; Buca D; Buca D; Rosini S
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28696386
[TBL] [Abstract][Full Text] [Related]
35. 5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.
Westre B; Giske A; Guttormsen H; Sørbye SW; Skjeldestad FE
BMC Clin Pathol; 2016; 16():9. PubMed ID: 27279798
[TBL] [Abstract][Full Text] [Related]
36. HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
PLoS One; 2014; 9(11):e112934. PubMed ID: 25405981
[TBL] [Abstract][Full Text] [Related]
37. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
38. HPV mRNA testing in triage of women with ASC-US cytology may reduce the time for CIN2+diagnosis compared with repeat cytology.
Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
Curr Pharm Des; 2013; 19(8):1401-5. PubMed ID: 23016772
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
